Noela Radu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Noela Radu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Denisa Muraru
Department of Medicine and Surgery, University of Milano-Bicocca , Piazza dell'Ateneo Nuovo 1, Milan 20126
4 shared publications - Luigi Pietro Badano
Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy; Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy
4 shared publications - Michele Tomaselli
Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy
4 shared publications - Claudia Baratto
Istituto Auxologico Italiano, IRCCS
3 shared publications - Sergio Caravita
University of Bergamo
3 shared publications - Alexandra Simona Buta
Department of Cardiology, Istituto Auxologico Italiano, IRCCS , Piazzale Brescia 20, Milan 20149
2 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
Tricuspid inflow E-wave velocity for the assessment of severe or greater tricuspid regurgitation: derivation and external validation of threshold values
Aims: Current guidelines include tricuspid inflow E-wave (>100 cm/s by pulsed-wave Doppler) as a semiquantitative criterion for diagnosing severe tricuspid regurgitation (TR), despite limited supporting evidence. We assessed its diagnostic performance for identifying severe or greater TR, deriving and externally validating practical thresholds. Methods and results: Tricuspid inflow E-wave velocity was measured by pulsed-wave Doppler in consecutive patients with at least mild TR between December 2024 and February 2026. Among 178 patients (77 ± 13 years, 65% women), TR was mild in 44, moderate in 61, severe in 44, massive in 15, and torrential in 14. Mean tricuspid E-wave velocity was 56 ± 16 cm/s and increased with TR severity: 47 ± 8, 50 ± 10, 62 ± 16, 67 ± 13, and 77 ± 21 cm/s for mild, moderate, severe, massive, and torrential TR, respectively. Only three patients had E-wave velocity >100 cm/s (one with severe and two with torrential TR). Using multiparametric echocardiographic grading as the reference standard, the >100 cm/s threshold showed 5.5% sensitivity, 100% specificity, and kappa 0.25 for severe or greater TR. As a continuous variable, E-wave velocity discriminated severe or greater TR with an Area under the receiver operating characteristic curve of 0.81. A lower threshold of 52 cm/s yielded 81% sensitivity and 67% specificity, whereas 47 cm/s provided 90% sensitivity and 43% specificity. External validation resulted in 94% sensitivity and 47% specificity. Conclusion: The guideline-recommended threshold of >100 cm/s is highly insensitive for detecting severe or greater TR. Lower cut-offs, particularly 47 cm/s, may be useful for screening to trigger a comprehensive multiparametric assessment.
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
Open AccessTricuspid inflow E-wave velocity for the assessment of severe or greater tricuspid regurgitation: derivation and external validation of threshold values
Aims: Current guidelines include tricuspid inflow E-wave (>100 cm/s by pulsed-wave Doppler) as a semiquantitative criterion for diagnosing severe tricuspid regurgitation (TR), despite limited supporting evidence. We assessed its diagnostic performance for identifying severe or greater TR, deriving and externally validating practical thresholds. Methods and results: Tricuspid inflow E-wave velocity was measured by pulsed-wave Doppler in consecutive patients with at least mild TR between December 2024 and February 2026. Among 178 patients (77 ± 13 years, 65% women), TR was mild in 44, moderate in 61, severe in 44, massive in 15, and torrential in 14. Mean tricuspid E-wave velocity was 56 ± 16 cm/s and increased with TR severity: 47 ± 8, 50 ± 10, 62 ± 16, 67 ± 13, and 77 ± 21 cm/s for mild, moderate, severe, massive, and torrential TR, respectively. Only three patients had E-wave velocity >100 cm/s (one with severe and two with torrential TR). Using multiparametric echocardiographic grading as the reference standard, the >100 cm/s threshold showed 5.5% sensitivity, 100% specificity, and kappa 0.25 for severe or greater TR. As a continuous variable, E-wave velocity discriminated severe or greater TR with an Area under the receiver operating characteristic curve of 0.81. A lower threshold of 52 cm/s yielded 81% sensitivity and 67% specificity, whereas 47 cm/s provided 90% sensitivity and 43% specificity. External validation resulted in 94% sensitivity and 47% specificity. Conclusion: The guideline-recommended threshold of >100 cm/s is highly insensitive for detecting severe or greater TR. Lower cut-offs, particularly 47 cm/s, may be useful for screening to trigger a comprehensive multiparametric assessment.
- Open Access
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e049040
Right Heart Remodeling Redefines Risk in Significant Secondary Tricuspid Regurgitation Without Indication for Intervention
Background: The prognostic significance of right heart remodeling (RHR) in patients with secondary tricuspid regurgitation (STR) who do not meet guideline‐based indications for tricuspid valve surgery remains uncertain. We evaluated whether advanced markers of RHR are associated with outcomes in medically managed patients with significant STR. Methods: We retrospectively included 755 patients with significant STR (age 75±12 years). Patients were stratified into 3 groups: Group 1, no current surgical indication (n=519); Group 2, meeting Class I/IIa guideline criteria (n=144); and Group 3, deemed inoperable (n=92). RHR markers included right atrial volume index, right ventricular end‐diastolic volume index, forward stroke volume/right ventricular end‐systolic volume ratio, and effective right ventricular ejection fraction. The primary end point was a composite of all‐cause mortality or heart failure hospitalization. Results: Group 1 patients had less severe STR and less advanced right ventricular remodeling than Groups 2 and 3. Over a median follow‐up of 24 months (interquartile range, 11–34), 330 primary events occurred; 64 patients underwent tricuspid valve intervention. In Group 1, 30‐month event‐free survival was 71±4% with no RHR markers, 65±3% with 1 or 2 markers, and 33±9% with ≥3 markers (adjusted hazard ratio [aHR], 2.76 [95% CI, 1.74–4.37]; P P P <0.001). Conclusions: Among patients with significant STR without surgical indications, ≥3 markers of RHR identify a high‐risk phenotype with outcomes similar to those meeting surgical criteria or considered inoperable.
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e049040
Open AccessRight Heart Remodeling Redefines Risk in Significant Secondary Tricuspid Regurgitation Without Indication for Intervention
Background: The prognostic significance of right heart remodeling (RHR) in patients with secondary tricuspid regurgitation (STR) who do not meet guideline‐based indications for tricuspid valve surgery remains uncertain. We evaluated whether advanced markers of RHR are associated with outcomes in medically managed patients with significant STR. Methods: We retrospectively included 755 patients with significant STR (age 75±12 years). Patients were stratified into 3 groups: Group 1, no current surgical indication (n=519); Group 2, meeting Class I/IIa guideline criteria (n=144); and Group 3, deemed inoperable (n=92). RHR markers included right atrial volume index, right ventricular end‐diastolic volume index, forward stroke volume/right ventricular end‐systolic volume ratio, and effective right ventricular ejection fraction. The primary end point was a composite of all‐cause mortality or heart failure hospitalization. Results: Group 1 patients had less severe STR and less advanced right ventricular remodeling than Groups 2 and 3. Over a median follow‐up of 24 months (interquartile range, 11–34), 330 primary events occurred; 64 patients underwent tricuspid valve intervention. In Group 1, 30‐month event‐free survival was 71±4% with no RHR markers, 65±3% with 1 or 2 markers, and 33±9% with ≥3 markers (adjusted hazard ratio [aHR], 2.76 [95% CI, 1.74–4.37]; P P P <0.001). Conclusions: Among patients with significant STR without surgical indications, ≥3 markers of RHR identify a high‐risk phenotype with outcomes similar to those meeting surgical criteria or considered inoperable.
- Open Access
- 1 June 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (6) , e014201
Right Ventricular Contractile Reserve in Heart Failure With Preserved Ejection Fraction
- 1 June 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (6) , e014201
Open AccessRight Ventricular Contractile Reserve in Heart Failure With Preserved Ejection Fraction
- 23 June 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 23 (11) , 1459-1470
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity
In functional tricuspid regurgitation (FTR) patients, tricuspid leaflet tethering and relatively low jet velocity could result in proximal flow geometry distortions that lead to underestimation of TR. Application of correction factors on two-dimensional (2D) proximal isovelocity surface area (PISA) equation may increase its reliability. This study sought to evaluate the impact of the corrected 2D PISA method in quantifying FTR severity. In 102 patients with FTR, we compared both conventional and corrected 2D PISA measurements of effective regurgitant orifice area [EROA vs. corrected (EROAc)] and regurgitant volume (RegVol vs. RegVolc) with those obtained by volumetric method (VM) using three-dimensional echocardiography (3DE), as reference. Both EROAc and RegVolc were larger than EROA (0.29 ± 0.26 vs. 0.22 ± 0.21 cm2; P < 0.001) and RegVol (24.5 ± 20 vs. 18.5 ± 14.25 mL; P < 0.001), respectively. Compared with VM, both EROAc and RegVolc resulted more accurate than EROA [bias = −0.04 cm2, limits of agreement (LOA) ± 0.02 cm2 vs. bias = −0.15 cm2, LOA ± 0.31 cm2] and RegVol (bias = −3.29 mL, LOA ± 2.19 mL vs. bias = −10.9 mL, LOA ± 13.5 mL). Using EROAc and RegVolc, 37% of patients were reclassified in higher grades of FTR severity. Corrected 2D PISA method led to a higher concordance of TR severity grade with the VM method (ĸ = 0.84 vs. ĸ = 0.33 for uncorrected PISA, P < 0.001). Compared with VM by 3DE, the conventional PISA underestimated FTR severity in about 50% of patients. Correction for TV leaflets tethering angle and lower velocity of FTR jet improved 2D PISA accuracy and reclassified more than one-third of the patients. Compared to the volumetric method by 3DE, the conventional PISA underestimated functional tricuspid regurgitation severity in about 50% of patients. Correction for tricuspid valve leaflets tethering angle and lower velocity of functional tricuspid regurgitation jet improved 2D PISA accuracy and reclassified more than one third of the patients. Compared to the volumetric method by 3DE, the conventional PISA underestimated functional tricuspid regurgitation severity in about 50% of patients. Correction for tricuspid valve leaflets tethering angle and lower velocity of functional tricuspid regurgitation jet improved 2D PISA accuracy and reclassified more than one third of the patients.
- 23 June 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 23 (11) , 1459-1470
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity
In functional tricuspid regurgitation (FTR) patients, tricuspid leaflet tethering and relatively low jet velocity could result in proximal flow geometry distortions that lead to underestimation of TR. Application of correction factors on two-dimensional (2D) proximal isovelocity surface area (PISA) equation may increase its reliability. This study sought to evaluate the impact of the corrected 2D PISA method in quantifying FTR severity. In 102 patients with FTR, we compared both conventional and corrected 2D PISA measurements of effective regurgitant orifice area [EROA vs. corrected (EROAc)] and regurgitant volume (RegVol vs. RegVolc) with those obtained by volumetric method (VM) using three-dimensional echocardiography (3DE), as reference. Both EROAc and RegVolc were larger than EROA (0.29 ± 0.26 vs. 0.22 ± 0.21 cm2; P < 0.001) and RegVol (24.5 ± 20 vs. 18.5 ± 14.25 mL; P < 0.001), respectively. Compared with VM, both EROAc and RegVolc resulted more accurate than EROA [bias = −0.04 cm2, limits of agreement (LOA) ± 0.02 cm2 vs. bias = −0.15 cm2, LOA ± 0.31 cm2] and RegVol (bias = −3.29 mL, LOA ± 2.19 mL vs. bias = −10.9 mL, LOA ± 13.5 mL). Using EROAc and RegVolc, 37% of patients were reclassified in higher grades of FTR severity. Corrected 2D PISA method led to a higher concordance of TR severity grade with the VM method (ĸ = 0.84 vs. ĸ = 0.33 for uncorrected PISA, P < 0.001). Compared with VM by 3DE, the conventional PISA underestimated FTR severity in about 50% of patients. Correction for TV leaflets tethering angle and lower velocity of FTR jet improved 2D PISA accuracy and reclassified more than one-third of the patients. Compared to the volumetric method by 3DE, the conventional PISA underestimated functional tricuspid regurgitation severity in about 50% of patients. Correction for tricuspid valve leaflets tethering angle and lower velocity of functional tricuspid regurgitation jet improved 2D PISA accuracy and reclassified more than one third of the patients. Compared to the volumetric method by 3DE, the conventional PISA underestimated functional tricuspid regurgitation severity in about 50% of patients. Correction for tricuspid valve leaflets tethering angle and lower velocity of functional tricuspid regurgitation jet improved 2D PISA accuracy and reclassified more than one third of the patients.